Similar articles

• [Spectroscopy of phosphorus in nuclear magnetic resonance. General review of clinical applications to the study of human skeletal muscle].

  Kaminsky P, Escanyé JM, Klein M, Robin-Lherbier B, Walker P, Robert J, Duc M. Kaminsky P, et al. Rev Med Interne. 1991 Mar-Apr;12(2):128-30, 133-8. doi: 10.1016/s0248-8663(05)81376-1. Rev Med Interne. 1991. PMID: 1852995 Review. French.
• [31P NMR spectroscopy of muscular diseases: correlation with MR imaging].

  Kaiser WA, Hartl W, Sturm H, Schalke BC, Zeitler E. Kaiser WA, et al. Rofo. 1987 Feb;146(2):137-44. doi: 10.1055/s-2008-1048459. Rofo. 1987. PMID: 3029825 German.
• Clinical use of nuclear magnetic resonance in the investigation of myopathy.

  Edwards RH, Dawson MJ, Wilkie DR, Gordon RE, Shaw D. Edwards RH, et al. Lancet. 1982 Mar 27;1(8274):725-31. doi: 10.1016/s0140-6736(82)92635-6. Lancet. 1982. PMID: 6122019 No abstract available.
• [In vivo P-31 NMR spectroscopy study of muscle metabolism in disease and under the influence of drugs].

  Jehenson P, Duboc D, Fardeau M, Syrota A. Jehenson P, et al. Therapie. 1987 Sep;42(5):467-70. Therapie. 1987. PMID: 2894723 French. No abstract available.
• Clinical aspects on 31P NMR spectroscopy.

  Radda GK, Bore PJ, Rajagopalan B. Radda GK, et al. Br Med Bull. 1984 Apr;40(2):155-9. doi: 10.1093/oxfordjournals.bmb.a071962. Br Med Bull. 1984. PMID: 6378313 Review. No abstract available.